metricas
covid
Buscar en
Vacunas
Toda la web
Inicio Vacunas Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online ...
Información de la revista
Vol. 23. Núm. S2.
Vacunas COVID-19: desarrollo y práctica - COVID-19 vaccines: development and practice
Páginas S60-S66 (septiembre - diciembre 2022)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
1159
Vol. 23. Núm. S2.
Vacunas COVID-19: desarrollo y práctica - COVID-19 vaccines: development and practice
Páginas S60-S66 (septiembre - diciembre 2022)
Original
Acceso a texto completo
Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece
Evaluación transversal de los factores predictivos de la aceptación de la vacuna contra la COVID-19: Encuesta online en Grecia
Visitas
1159
Petros Galanisa,
Autor para correspondencia
pegalan@nurs.uoa.gr

Corresponding author at: Clinical Epidemiology Laboratory, Faculty of Nursing, National and Kapodistrian University of Athens, 123 Papadiamantopoulou street, GR-11527, Athens, Greece.
, Irene Vrakab, Olga Siskouc, Olympia Konstantakopoulouc, Aglaia Katsiroumpaa, Ioannis Moisogloud, Daphne Kaitelidouc
a Clinical Epidemiology Laboratory, Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece
b Department of Radiology, P & A Kyriakou Children's Hospital, Athens, Greece
c Center for Health Services Management and Evaluation, Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece
d Pulmonary Clinic, General Hospital of Lamia, Lamia, Greece
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (3)
Table 1. Socio-demographic characteristics of the participants.
Table 2. Participants' attitudes towards COVID-19 vaccination and pandemic.
Table 3. Univariate and multivariate logistic regression analysis with COVID-19 vaccine uptake among the participants as the dependent variable (reference: COVID-19 vaccine denial).
Mostrar másMostrar menos
Suplemento especial
Este artículo forma parte de:
Vol. 23. Núm S2

Vacunas COVID-19: desarrollo y práctica - COVID-19 vaccines: development and practice

Más datos
Abstract
Objective

To estimate the percentage of the general population vaccinated against the COVID-19 and to investigate the factors associated with COVID-19 vaccine uptake.

Material and methods

We conducted an online cross-sectional study in Greece during August 2021. We included individuals over 18 years of age. Independent variables included socio-demographic data of the participants and attitudes towards COVID-19 vaccination and pandemic. Our outcome variable was COVID-19 vaccination status, measured through “yes/no” answers.

Results

Most participants had been vaccinated against the COVID-19 (87.8%). Multivariate analysis identified that increased age and a higher level of education were associated with an increased likelihood of COVID-19 vaccination. Also, participants working in health services, participants without a previous COVID-19 diagnóstico, and those with previous seasonal influenza vaccination history had a greater probability to take a COVID-19 vaccine. Additionally, increased self-perceived severity of COVID-19, knowledge regarding COVID-19, and trust in COVID-19 vaccines and scientists were associated with COVID-19 vaccine uptake. On the other hand, the likelihood of vaccination was lower for participants who were more concerned about the side effects of COVID-19 vaccination.

Conclusions

Understanding the factors affecting individuals' decision to take a COVID-19 vaccine is essential to improve the COVID-19 vaccination coverage rate. Policymakers and scientists should scale up their efforts to increase the COVID-19 vaccination rate among specific population groups such as young people, people with a low level of education, etc.

Keywords:
COVID-19
General population
Vaccine uptake
Greece
Resumen
Objetivo

Calcular el porcentaje de población general vacunada contra la COVID-19 e investigar los factores asociados a la aceptación de dicha vacuna.

Material y métodos

Realizamos un estudio transversal online en Grecia durante el mes de agosto de 2021, en el que incluimos a individuos mayores de 18 años de edad. Las variables independientes incluyeron los datos sociodemográficos de los participantes y las actitudes hacia la vacunación y la pandemia de COVID-19. Nuestra variable del resultado fue la situación de vacunación contra la COVID-19, medida mediante respuestas “sí/no”.

Resultados

La mayoría de los participantes habían sido vacunados contra la COVID-19 (87,8%). El análisis multivariante identificó que el incremento de la edad y el mayor nivel educativo estaban asociados a un aumento de la probabilidad de vacunarse contra la COVID-19. De igual modo, los participantes que trabajaban en servicios sociales, aquellos participantes sin un diagnóstico previo de COVID-19, y aquellos con historial previo de vacuna contra la gripe estacional tenían una mayor probabilidad de vacunarse contra la COVID-19. Además, el incremento de la gravedad autopercibida de la COVID-19, el conocimiento sobre la enfermedad, y la confianza en las vacunas contra la COVID-19 y en los científicos estuvieron asociados a la aceptación de la vacuna. Por otro lado, la probabilidad de vacunarse fue menor en los participantes más preocupados de los efectos secundarios de la vacuna contra la COVID-19.

Conclusiones

Comprender los factores que afectan a la decisión de los individuos sobre la vacunación contra la COVID-19 es fundamental para mejorar la tasa de cobertura de dicha vacunación. Los responsables políticos y los científicos deberán redoblar sus esfuerzos para incrementar la tasa de vacunación contra la COVID-19 entre los grupos de población específicos tales como la gente joven, las personas con un bajo nivel educativo, etc.

Palabras clave:
COVID-19
Población general
Aceptación de la vacuna
Grecia
Texto completo
Introduction

Until September 2021, the Coronavirus disease 2019 (COVID-19) pandemic has caused more than 4.7 million deaths and 230 million cases.36 COVID-19 vaccination is regarded as the most promising means of controlling the COVID-19 pandemic. However, there is a critical need for effective vaccine uptake in the general population to approach herd immunity. COVID-19 vaccine acceptance shows a great variability across countries or regions which may affect the efforts to contain the pandemic.4 According to meta-analyses,29,32 the average COVID-19 vaccine acceptance rate in the general population is about 73% which is lower than the percentage estimated to be sufficient for reaching herd immunity threshold with a COVID-19 vaccine that is at least 80% effective.5 Moreover, the longer the COVID-19 pandemic lasts, the smaller rate of the general population wants to get vaccinated.29 The situation may get worse as the real-world COVID-19 vaccine uptake may be lower than the acceptance rate.

Predictors of COVID-19 vaccine acceptance are well known. In particular, socio-demographic variables (e.g. gender, age, race/ethnicity, and educational level), influenza vaccination history, self-protection from COVID-19, risk perception of COVID-19 infection, fear of COVID-19, concerns about the efficacy, side effects and safety of COVID-19 vaccines, and trust in authorities are the most prominent factors associated with COVID-19 vaccination willingness.3,16,32

Several studies have investigated the predictors for COVID-19 vaccine uptake in the general population.1,2,13,18,19,21,23,27,30,35,38 Furthermore, these studies investigated several demographic, health condition and lifestyle characteristics of the general population, such as gender, age, race/ethnicity educational level, living status, profession, income, perceived health status, chronic medical conditions, smoking status, perceived COVID-19 exposure, knowledge of COVID-19, contact with known/suspected case of COVID-19, sources of knowledge about COVID-19 vaccines, etc. Thus, our objectives were (i) to estimate the percentage of the general population vaccinated against the COVID-19 and (ii) to investigate the factors associated with COVID-19 vaccine uptake.

Materials and methods

Study design and participants.

We conducted an online cross-sectional study in Greece. We included individuals over 18 years of age. By the beginning of 2021 until the time of the study, a free COVID-19 vaccine had already been offered to all adults residents of Greece by the Greek government. In more detail, on the 11th January 2021, Greece approves a COVID-19 vaccine for the general population. The Greek government initially targeted vaccination of vulnerable groups and gradually by June 2021 the ability of free vaccination was given to all adults. COVID-19 vaccination was voluntary and even those diagnosed with the COVID-19 could be vaccinated. We created an anonymous version of the study questionnaire using google forms and all the participants provided informed consent to participate in the study. The questionnaire was accompanied by a detailed explanation of the study design and was distributed through social media. The study questionnaire was available between August 10th – 20th, 2021, and 1959 participants completed the survey during this time frame. The questionnaire was distributed through social media of the authors and a convenience sample was obtained. Given that the percentage of adults who are vaccinated against the COVID-19 during our study is unknown, we considered a prevalence of 50% to estimate the largest sample size. Considering the confidence level as 95% and the precision level as ±5%, a sample size of 385 adults was obtained. Then, we decided to substantially increase the sample size to minimize random error. The study protocol was approved by the Ethics Committee of the Department of Nursing, National and Kapodistrian University of Athens (reference number; 370, 02-09-2021).

Independent variables and outcome.

Independent variables included socio-demographic data of the participants and attitudes towards COVID-19 vaccination and pandemic. All survey items were self-reported. Regarding socio-demographic data, we collected information on gender, age, marital status, children <18 years old, educational level (elementary school, high school, or university degree), MSc/PhD degree, working on healthcare facilities, self-perceived financial status and health status, chronic disease, previous COVID-19 diagnóstico, family/friends with previous COVID-19 diagnóstico, and living with elderly people or vulnerable groups during the COVID-19 pandemic. Responses in financial status and health status ranged from 0 = “very poor” to 4 = “very good”. We measured seasonal influenza vaccination in 2020 with “yes/no” answers. Also, we measured self-perceived severity of COVID-19, self-perceived knowledge regarding COVID-19 and COVID-19 vaccines, trust in COVID-19 vaccines, trust in the government, scientists, and family doctors regarding the information about the COVID-19 vaccines, and concerns about the side effects of COVID-19 vaccination. Responses ranged from 0 to 10 with higher values indicate higher levels of self-perceived severity of COVID-19, knowledge, trust, and concerns. We averaged item responses to create continuous variables.

Our outcome variable was COVID-19 vaccination status, measured through “yes/no” answers. Also, we collected information on the possible reasons for the decline of COVID-19 vaccination.

Statistical analysis

We used numbers (percentages) to present categorical variables and mean (standard deviation) to present continuous variables. To investigate predictors of COVID-19 vaccine uptake, we used logistic regression analysis. First, a univariate logistic regression analysis was fit to identify which variables were associated with accepting a COVID-19 vaccine. Then, a multivariate logistic regression analysis was applied to find the independent predictors of COVID-19 vaccination. The multivariate model included the variables that in the univariate analysis had a p-value <0.05. A backward stepwise model was applied and adjusted odds ratios (OR), 95% confidence intervals (CI), and two-sided p-values were presented. In multivariate model, p-value<0.05 was considered significant. Statistical analysis was performed with the Statistical Package for Social Sciences software (IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp.).

Results

Detailed socio-demographic characteristics of the 1959 participants are shown in Table 1. Mean age of the participants was 41.5 years old. Most of the participants were females (75.3%) and married (64.3%). Among them, 81% had a University degree and 42.4% had a MSc/PhD degree. Regarding the COVID-19 status, 9.5% of the participants were diagnosed with COVID-19 and 57% had family/friends with a previous COVID-19 diagnóstico. The majority of the participants considered their financial status as moderate/good (83%) and their health status as good/very good (79.1%).

Table 1.

Socio-demographic characteristics of the participants.

Characteristics 
Gender     
Females  1476  75.3 
Males  483  24.7 
Age (years)a  41.5  10.6 
Marital status     
Singles  553  28.2 
Married  1260  64.3 
Widowed  135  6.9 
Divorced  11  0.6 
Children <18 years old     
No  919  46.9 
Yes  1040  53.1 
Educational level     
Elementary school  28  1.2 
High school  345  17.6 
University degree  1586  81.0 
MSc/PhD degree     
No  1129  57.6 
Yes  830  42.4 
Working on healthcare facilities     
No  1036  52.9 
Yes  923  47.1 
Self-perceived financial status     
Very poor  40  2.0 
Poor  194  9.9 
Moderate  1096  55.9 
Good  530  27.1 
Very good  99  5.1 
Self-perceived health status     
Very poor  0.5 
Poor  50  2.6 
Moderate  351  17.9 
Good  973  49.7 
Very good  576  29.4 
Chronic disease     
No  1522  77.7 
Yes  437  22.3 
Previous COVID-19 diagnóstico     
No  1773  90.5 
Yes  186  9.5 
Family/friends with previous COVID-19 diagnóstico     
No  842  43.0 
Yes  1117  57.0 
Living with elderly people or vulnerable groups during the COVID-19 pandemic     
No  1354  69.1 
Yes  605  30.9 
a

Mean, standard deviation.

We presented participants' attitudes towards COVID-19 vaccination and pandemic in Table 2. Most participants had been vaccinated against the COVID-19 (87.8%), while about half had been vaccinated against influenza (52.5%). The main reasons for refusing COVID-19 vaccination were concerns about the safety and effectiveness of COVID-19 vaccines (43.8%), concerns about the side effects of COVID-19 vaccines (22.7%), previous COVID-19 diagnóstico (10.7%), and females' effort to get pregnant (8.2%). Self-perceived severity of COVID-19 and concerns about the side effects of COVID-19 vaccination were moderate, while knowledge regarding COVID-19 and COVID-19 vaccines was high. Participants had more confidence in family doctors and scientists than in the government regarding the information about the COVID-19 vaccines.

Table 2.

Participants' attitudes towards COVID-19 vaccination and pandemic.

 
COVID-19 vaccination     
No  239  12.2 
Yes  1720  87.8 
Seasonal influenza vaccination in 2020     
No  931  47.5 
Yes  1028  52.5 
Reasons for decline of COVID-19 vaccination     
I have doubts about the safety and effectiveness of COVID-19 vaccines  102  43.8 
I am afraid of side effects of COVID-19 vaccines  53  22.7 
I believe that I will not be infected by COVID-19  0.4 
I believe that even if I get infected with COVID-19, nothing bad will happen to me  3.0 
I have already been diagnosed with COVID-19 and the vaccine will not be beneficial for me  25  10.7 
I am afraid because I suffer from a chronic disease  3.4 
Family physician does not allow me to take a COVID-19 vaccine due to my medical condition  1.7 
My religion does not allow me to take a COVID-19 vaccine  1.3 
I am trying to get pregnant  19  8.2 
I am afraid because I am pregnant  11  4.7 
Self-perceived severity of COVID-19a  4.6  2.7 
Self-perceived knowledge regarding COVID-19a  8.9  1.3 
Self-perceived knowledge regarding COVID-19 vaccinesa  8.6  1.7 
Trust in the government regarding the information about the COVID-19 vaccinesa  5.2  3.4 
Trust in scientists regarding the information about the COVID-19 vaccinesa  7.5  2.9 
Trust in family doctors regarding the information about the COVID-19 vaccinesa  8.2  2.1 
Concerns about the side effects of COVID-19 vaccinationa  5.6  3.1 
Trust in COVID-19 vaccinesa  7.3  2.8 
a

Mean, standard deviation.

Results of the univariate and multivariate logistic regression analysis are presented in Table 3. Multivariate logistic regression analysis identified that increased age was associated with an increased likelihood of COVID-19 vaccination. Also, participants with a higher level of education and those working in health services had a greater probability to take a COVID-19 vaccine. Participants without a previous COVID-19 diagnóstico and those with previous seasonal influenza vaccination history were more frequently vaccinated against the COVID-19. Additionally, increased self-perceived severity of COVID-19, knowledge regarding COVID-19, and trust in COVID-19 vaccines and scientists regarding the information about the COVID-19 vaccines were associated with COVID-19 vaccine uptake. On the other hand, the likelihood of vaccination was lower for participants who were more concerned about the side effects of COVID-19 vaccination and those who trusted family doctors more for COVID-19 vaccine information.

Table 3.

Univariate and multivariate logistic regression analysis with COVID-19 vaccine uptake among the participants as the dependent variable (reference: COVID-19 vaccine denial).

Variable  Unadjusted OR (95% CI)  P-value  Adjusted OR (95% CI)a  P-value 
Gender (females vs. males)  1.37 (1.02–1.85)  0.04  NS   
Age (years)  1.02 (1.01–1.03)  0.003  1.04 (1.02–1.06)  <0.001 
Marital status (married vs. singles/widowed/divorced)  0.91 (0.69–1.22)  0.54  NS   
Children <18 years old (no vs. yes)  1.57 (1.19–2.08)  0.001  NS   
Educational level         
Elementary school  1 (reference)       
High school  1.19 (0.47–3.07)  0.71  6.29 (1.41–28.17)  0.02 
University degree  2.29 (0.91–5.72)  0.08  7.78 (1.77–34.20)  0.01 
MSc/PhD degree (yes vs. no)  1.41 (1.07–1.87)  0.02  1.68 (1.06–2.67)  0.03 
Self-perceived financial status      NS   
Good/very good  2.42 (1.39–2.89)  <0.001     
Moderate  2.00 (1.39–2.89)  <0.001     
Very poor/poor  1 (reference)       
Self-perceived health status      NS   
Good/very good  1.29 (0.63–2.67)  0.49     
Moderate  1.36 (0.62–2.97)  0.44     
Very poor/poor  1 (reference)       
Chronic disease (yes vs. no)  1.02 (0.74–1.41)  0.91  NS   
Previous COVID-19 diagnóstico (no vs. yes)  3.63 (2.56–5.15)  <0.001  5.45 (3.03–9.83)  <0.001 
Family/friends with COVID-19 disease (no vs. yes)  1.52 (1.14–2.01)  0.004  NS   
Living with elderly people or vulnerable groups during the COVID-19 pandemic (yes vs. no)  1.04 (0.78–1.40)  0.79  NS   
Working on health facilities (yes vs. no)  1.25 (0.95–1.64)  0.11  1.84 (1.19–2.83)  0.005 
Seasonal influenza vaccination in 2020 (yes vs. no)  5.42 (3.89–7.57)  <0.001  2.55 (1.59–4.05)  <0.001 
Self-perceived severity of COVID-19  1.19 (1.13–1.26)  <0.001  1.13 (1.02–1.24)  0.02 
Self-perceived knowledge regarding COVID-19  1.27 (1.16–1.38)  <0.001  1.23 (1.04–1.45)  0.02 
Self-perceived knowledge regarding COVID-19 vaccines  1.22 (1.14–1.30)  <0.001  0.79 (0.69–0.90)  <0.001 
Trust in the government regarding the information about the COVID-19 vaccines  1.53 (1.44–1.62)  <0.001  NS   
Trust in scientists regarding the information about the COVID-19 vaccines  1.56 (1.49–1.64)  <0.001  1.13 (1.03–1.23)  0.009 
Trust in family doctors regarding the information about the COVID-19 vaccines  1.45 (1.36–1.53)  <0.001  0.87 (0.78–0.96)  0.008 
Concerns about the side effects of COVID-19 vaccination  0.57 (0.52–0.61)  <0.001  0.80 (0.73–0.89)  <0.001 
Trust in COVID-19 vaccines  1.85 (1.74–1.96)  <0.001  1.66 (1.48–1.86)  <0.001 

An odds ratio < 1 indicates a negative association, while an odds ratio > 1 indicates a positive association.

CI: confidence interval; NS: not selected by the backward elimination procedure in the multivariable logistic regression analysis with a significance level set at 0.05; OR: odds ratio.

a

R2 for the final multivariate model was 62%.

Discussion

Our study investigated the factors that influence the decision of the general population to be vaccinated against the COVID-19. It is highly encouraging that the majority of participants had been vaccinated against the COVID-19 (87.8%). In similar studies, this rate was 28.6% in the USA and the United Kingdom,23 94.1% in the United Kingdom,13 98% in the USA,21 50.8% in Hong Kong,35 and 22.4% in Saudi Arabia.1 In addition, we found that the most important reasons why participants were not vaccinated were concerns about the safety, effectiveness and side effects of COVID-19 vaccines, previous COVID-19 diagnóstico, and females' effort to get pregnant. Literature confirms this finding with studies conducted not only in the general population but also in patients and health professionals.11

Another interesting finding of our study was the seasonal influenza vaccination rate in 2020. This rate (52.5%) was high since worldwide the influenza vaccination rate does not exceed 30%.6,7,31 However, it is possible that the high influenza vaccination rate in 2020 may be due to the findings of studies that show that influenza vaccination is associated with a lower risk of SARS-CoV-2 infection.33 In any case, the high influenza vaccination rate is an extremely encouraging fact indicating the positive attitude of the participants towards vaccination.

We studied several demographic characteristics of participants and we found that age, educational level, and working in health services were associated with vaccination. More specifically, increased age was associated with an increased likelihood of vaccination. This finding is confirmed by studies in the general population and healthcare workers.1,19,21 This result can be attributed to the fact that from the beginning of the COVID-19 pandemic, increased age has been found to be associated with worse outcomes such as admission to an intensive care unit and death22,28,37 Probably, older people may confront COVID with more fear and anxiety, resulting in a higher rate of vaccination. This thought is strengthened by our findings that increased self-perceived severity of COVID-19 and the absence of COVID-19 diagnóstico in the past were associated with an increased likelihood of COVID-19 vaccination. Several studies confirm these results.19,24,25,35 Risk perception regarding the COVID-19 is crucial in the decision of individuals to be vaccinated, since the intention to vaccinate is higher among those who consider the COVID-19 to be dangerous and life-threatening.8,14,17,34 In addition, it is possible that past COVID-19 patients may feel that they have acquired immunity against the virus and are not so afraid of the negative clinical outcomes.24,25 On the contrary, individuals without a history of COVID-19 infection may feel more vulnerable and therefore decide to vaccinate.

Our multivariate regression model revealed that participants with a higher level of education were more frequently vaccinated against the COVID-19. This finding echoes the results of research which show higher COVID-19 vaccine uptake among more educated individuals.20,24,25 In general, people with higher socioeconomic status are more frequently vaccinated against the COVID-19.1,20,21,35 It is possible that a higher level of education enables people to better understand the vast amount of information about the pandemic. This is supported by our finding that increased knowledge regarding COVID-19 was related to an increased likelihood of vaccination. Better information about the COVID-19 pandemic and vaccines enables people to detect fake news. Thus, a relationship of trust is created between individuals and scientists reducing vaccine hesitancy.9,15 Our study and the literature confirm this finding since increased trust in COVID-19 vaccines and scientists is associated with an increased likelihood of COVID-19 vaccination.2,23 Moreover, increased trust in COVID-19 vaccines and scientists could reduce concerns about the safety and effectiveness of COVID-19 vaccines that are the main reason for decline of COVID-19 vaccination.12,20,23,26

We found that participants with previous seasonal influenza vaccination history had a greater probability to take a COVID-19 vaccine. The relationship between influenza vaccination and the COVID-19 vaccine uptake in the general population has not been investigated but a systematic review has already shown the positive effect of influenza vaccination on the intention of healthcare workers to accept a COVID-19 vaccine.10 Acceptance of influenza vaccination is evidence of positive attitudes towards vaccination which also increases the likelihood of COVID-19 vaccine uptake even though knowledge of the general population regarding COVID-19 vaccines is much less than that of influenza vaccines.

Limitations

Our study had certain limitations. Our study population was large, but not representative since we used a convenience sample. For instance, the proportion of women, people with a high level of education, and workers in healthcare facilities was considerably higher in our study compared to the general population in Greece. Moreover, online surveys during the COVID-19 pandemic are a rational approach but diminish the representativeness of the study population since individuals with limited Internet access are less likely to participate. Additionally, the response rate and the profile of non-correspondents cannot be estimated in online surveys. Thus, it would be wise not to generalize our conclusions but to carry out studies with more representative samples. Information bias was possible in our study since the study questionnaire was self-administered and we cannot objectively verify self-reported vaccination. Anonymity in our study may have reduced this information bias. Finally, we have investigated several factors that may affect individuals' decision to uptake a COVID-19 vaccine, but there may be other factors influencing this decision.

Conclusions

We observed a high level of COVID-19 vaccine uptake in the Greek general population during the first seven months of the vaccine rollout. We found that several factors influence the decision of the general population to get vaccinated against the COVID-19, such as age, educational level, previous COVID-19 diagnóstico, previous seasonal influenza vaccination history, etc. Understanding the factors affecting individuals' decision to take a COVID-19 vaccine is essential to improve the COVID-19 vaccination coverage rate. Further research with more representative samples is needed to better understand how people decide to uptake a COVID-19 vaccine. Policymakers and scientists should scale up their efforts to increase the COVID-19 vaccination rate among specific population groups such as young people, people with a low level of education, people with negative attitudes towards vaccination, etc. Optimizing protection of the general population through vaccination is crucial to control the COVID-19 pandemic.

Funding

None.

Author contributions

Conceptualization: Petros Galanis, Irene Vraka, Daphne Kaitelidou.

Study design: Petros Galanis, Irene Vraka.

Data acquisition: Petros Galanis, Ioannis Moisoglou.

Formal analysis: Petros Galanis, Olympia Konstantakopoulou, Aglaia Katsiroumpa.

Supervision: Petros Galanis, Daphne Kaitelidou.

Writing original draft: Petros Galanis, Irene Vraka, Olga Siskou, Aglaia Katsiroumpa, Ioannis Moisoglou.

Writing, review and editing: Petros Galanis, Olga Siskou, Olympia Konstantakopoulou, Daphne Kaitelidou.

Acknowledgments

None.

References
[1]
K. Al-Mansour, S. Alyahya, F. AbuGazalah, K. Alabdulkareem.
Factors affecting COVID-19 vaccination among the general population in Saudi Arabia.
Healthcare, 9 (2021), pp. 1218
[2]
W.A. Al-Qerem, A.S. Jarab.
COVID-19 vaccination acceptance and its associated factors among a middle eastern population.
Front Public Health, 9 (2021),
[3]
B.A. AlShurman, A.F. Khan, C. Mac, M. Majeed, Z.A. Butt.
What demographic, social, and contextual factors influence the intention to use COVID-19 vaccines: a scoping review.
Int J Environ Res Public Health, 18 (2021), pp. 9342
[4]
J. Aw, J.J.B. Seng, S.S.Y. Seah, L.L. Low.
COVID-19 vaccine hesitancy-a scoping review of literature in high-income countries.
Vaccines, 9 (2021), pp. 900
[5]
S.M. Bartsch, K.J. O’Shea, M.C. Ferguson, M.E. Bottazzi, P.T. Wedlock, U. Strych, et al.
Vaccine efficacy needed for a COVID-19 Coronavirus vaccine to prevent or stop an epidemic as the sole intervention.
Am J Prev Med, 59 (2020), pp. 493-503
[6]
P.R. Blank, M. Schwenkglenks, T.D. Szucs.
Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons.
BMC Public Health, 8 (2008), pp. 272
[7]
P.R. Blank, M. Schwenkglenks, T.D. Szucs.
Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.
J Inf Secur, 58 (2009), pp. 446-458
[8]
M. Caserotti, P. Girardi, E. Rubaltelli, A. Tasso, L. Lotto, T. Gavaruzzi.
Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents.
[9]
E. Dubé, C. Laberge, M. Guay, P. Bramadat, R. Roy, J. Bettinger.
Vaccine hesitancy: an overview.
Hum Vaccin Immunother, 9 (2013), pp. 1763-1773
[10]
P. Galanis, I. Vraka, D. Fragkou, A. Bilali, D. Kaitelidou.
Intention of healthcare workers to accept COVID-19 vaccination and related factors: A systematic review and meta-analysis.
Asian Pac J Trop Med, 14 (2021), pp. 543
[11]
P. Galanis, I. Vraka, O. Siskou, O. Konstantakopoulou, A. Katsiroumpa, D. Kaitelidou.
Predictors of COVID-19 Vaccination Uptake and Reasons for Decline of Vaccination: A Systematic Review.
Public and Global Health, (2021),
[12]
S. Gibbon, E. McPhail, G. Mills, M. McBride, R. Storer, N. Taylor, et al.
Uptake of COVID-19 vaccination in a medium secure psychiatric hospital population.
[13]
B. Glampson, J. Brittain, A. Kaura, A. Mulla, L. Mercuri, S. Brett, et al.
North West London Covid-19 Vaccination Programme: Real-World Evidence for Vaccine uptake and Effectiveness.
Health Informatics, (2021),
[14]
A. Glöckner, A.R. Dorrough, T. Wingen, S. Dohle, et al.
The Perception of Infection Risks during the Early and Later Outbreak of COVID-19 in Germany: Consequences and Recommendations.
PsyArXiv, (2020),
[15]
D.A. Gust, A. Kennedy, I. Shui, P.J. Smith, G. Nowak, L.K. Pickering.
Parent attitudes toward immunizations and healthcare providers the role of information.
Am J Prev Med, 29 (2005), pp. 105-112
[16]
A. Joshi, M. Kaur, R. Kaur, A. Grover, D. Nash, A. El-Mohandes.
Predictors of COVID-19 vaccine acceptance, intention, and hesitancy: a scoping review.
Front Public Health, 9 (2021),
[17]
L.C. Karlsson, A. Soveri, S. Lewandowsky, L. Karlsson, H. Karlsson, S. Nolvi, et al.
Fearing the disease or the vaccine: the case of COVID-19.
Personal Individ Differ, 172 (2021),
[18]
S.E. Kreps, D.L. Kriner.
Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: evidence from a conjoint experiment.
Vaccine, 39 (2021), pp. 3250-3258
[19]
J.F.W. Lau, Y.L. Woon, C.T. Leong, H.S. Teh.
Factors influencing acceptance of the COVID-19 vaccine in Malaysia: a web-based survey.
Osong Public Health Res Perspect, 12 (2021), pp. 361-373
[20]
M. Malesza, M. Bozym.
Factors Influencing COVID-19 Vaccination Uptake in an Elderly Sample in Poland.
Public and Global Health, (2021), http://dx.doi.org/10.1101/2021.03.21.21254047
[21]
S.D. McCabe, E.A. Hammershaimb, D. Cheng, A. Shi, D. Shyr, S. Shen, et al.
preprint, 7 April.
Unraveling Attributes of COVID-19 Vaccine Hesitancy and Uptake in the U.S.: A Large Nationwide Study,
[22]
E. Mehraeen, A. Karimi, A. Barzegary, F. Vahedi, A.M. Afsahi, O. Dadras, et al.
Predictors of mortality in patients with COVID-19-a systematic review.
Eur J Integrat Med, 40 (2020),
[23]
L.H. Nguyen, A.D. Joshi, D.A. Drew, J. Merino, W. Ma, C. Lo, et al.
Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake.
Epidemiology,
[24]
M.L. Pacella-LaBarbara, Y. Park, D. Patterson, A. Doshi, M.K. Guyette, A.H. Wong, et al.
COVID-19 vaccine uptake and intent among emergency healthcare workers: a cross-sectional survey.
[25]
M.L. Pacella-LaBarbara, Y.L. Park, P.D. Patterson, A. Doshi, M. Guyette, A.H. Wong, et al.
COVID-19 vaccine uptake and intent among emergency healthcare workers: a cross-sectional survey.
J Occup Environ Med, 63 (2021), pp. 852-856
[26]
W.A. Schrading, S.A. Trent, J.H. Paxton, R.M. Rodriguez, M.B. Swanson, N.M. Mohr, et al.
Vaccination rates and acceptance of SARS-CoV-2 vaccination among U.S. emergency department health care personnel.
Acad Emerg Med, 28 (2021), pp. 455-458
[27]
B.T. Seboka, D.E. Yehualashet, M.M. Belay, R.H. Kabthymer, H. Ali, S. Hailegebreal, et al.
Factors influencing COVID-19 vaccination demand and intent in resource-limited settings: based on health belief model.
Risk Manag Healthcare Pol, 14 (2021), pp. 2743-2756
[28]
M. Sepandi, M. Taghdir, Y. Alimohamadi, S. Afrashteh, H. Hosamirudsari.
Factors associated with mortality in COVID-19 patients: a systematic review and meta-analysis.
Iran J Public Health, 49 (2020), pp. 1211-1221
[29]
M. Snehota, J. Vlckova, K. Cizkova, J. Vachutka, H. Kolarova, E. Klaskova, et al.
Acceptance of a vaccine against COVID-19 - a systematic review of surveys conducted worldwide.
Bratisl Lek Listy, 122 (2021), pp. 538-547
[30]
K.K. Tong, M. He, A.M.S. Wu, L. Dang, J.H. Chen.
Cognitive factors influencing COVID-19 vaccination intentions: an application of the protection motivation theory using a probability community sample.
Vaccines, 9 (2021), pp. 1170
[31]
Q. Wang, N. Yue, M. Zheng, L. Lin.
Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis.
Vaccine, 36 (2018), pp. 7262-7269
[32]
Q. Wang, L. Yang, H. Jin, D. Wang, C. Duan, X. Yu, et al.
Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors.
[33]
R. Wang, M. Liu, J. Liu.
The association between influenza vaccination and COVID-19 and its outcomes: a systematic review and meta-analysis of observational studies.
[34]
J.K. Ward, C. Alleaume, P. Peretti-Watel, V. Seror, S. Cortaredona, O. Launay, et al.
The French public’s attitudes to a future COVID-19 vaccine: the politicization of a public health issue.
[35]
C.L. Wong, A.W.Y. Leung, O.M.H. Chung, W.T. Chien.
Factors influencing COVID-19 vaccination uptake among community members in Hong Kong: a cross-sectional online survey.
[36]
Worldometer (2021) COVID-19 coronavirus pandemic. Available at: https://www.worldometers.info/coronavirus/?fbclid=IwAR3T5FX-sv_X1GABioSDrcHEHSxg694_LZmDFQ3lFJjsBQQmiTemxcAow5k (accessed 22 September 2021).
[37]
N.D. Yanez, N.S. Weiss, J.-A. Romand, M.M. Treggiari.
COVID-19 mortality risk for older men and women.
BMC Public Health, 20 (2020), pp. 1742
[38]
Y. Yu, J.T.F. Lau, M.M.C. Lau, M.C.S. Wong, P.K.S. Chan, et al.
Understanding the prevalence and associated factors of behavioral intention of COVID-19 vaccination under specific scenarios combining effectiveness, safety, and cost in the hong kong chinese general population.
Int J Health Policy Manag, 1 (2021),
Copyright © 2022. Elsevier España, S.L.U.. All rights reserved
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos